CHEK2 and chronic myelogenous leukemia, BCR-ABL1 positive: For this purpose, immunofluorescence microscopy of γH2AX/53BP1 and Western blotting of (p-)ATM/(p-)CHK2 were applied in PBMC of CML patients at different disease stages in comparison to healthy controls.